Montorsi F, Guazzoni G, Consonni P, Colombo R, Nava L, Bergamaschi F, Scattoni V, Rigatti P: Confronto tra esplorazione rettale, ecografia transrettale, TAC e RMN nella stadiazione locale del carcinoma prostatico. Arch It Urol. LXIII ( suppl 1): 143-5, 1991.

Nava L, Consonni P, Guazzoni G, Montorsi F, Scattoni V, Da Pozzo L, Colombo R, Rigatti P: Biopsia prostatica ecoguidata transperineale e transrettale: complicanze delle due metodiche. Arch It Urol, LXV: 375-377, 1993.

Rigatti P, Da Pozzo L, Francesca F, Broglia L, Montorsi F, Guazzoni G, Scattoni V: Transcoccygeal radical prostatectomy for localized prostatic cancer: Early clinical results.  Eur Urol, 24 (suppl 2): 29-33, 1993.

Scattoni V, Broglia L, Da Pozzo L, Colombo R, De Cobelli F, Vanzulli A, Del Maschio A, Rigatti P: L'angiomiolipoma e l'oncocitoma renale: sensibilità, diagnosi e controversie alla TC e RM. Minerva Urol Nefrol; 45: 99-103, 1993.

Grasso M, Castelli M, Lania C, Scattoni V, Radice F, Rigatti P: Rivalutazione dell'impotenza erigendi insorgente dopo TURP. Minerva Urol Nefrol; 45: 105-108, 1993.

Broglia L, Scattoni V, Da Pozzo L, Rigatti P: A modified right angle clamp for radical retropubic prostatectomy and cystectomy. European Urolology.  26: 262-263, 1994.

Scattoni V, Colombo R, Nava L, Da Pozzo L, De Cobelli F, Vanzulli A, Del Maschio A, Freschi M, Rigatti P: Imaging of renal cell carcinoma with Gadolinium-enhanced magnetic resonance: Radiological and pathological study. Urologia Internationalis.  54:121-127, 1994.

Ambrosiani L, Bottanelli A, Marcelli G, Rovellini R, Scattoni V, Tavani E: Descrizione di un caso di angiomiolipoma renale con localizzazione linfonodale locoregionale associatoasclerosi tuberosa polmonare.  Arch It. Urol 67:283-287. 1995.

Francesca F, Scattoni V, Nava L, Pompa P, Grasso M, Rigatti P: Failures and complications of transurethral ureteroscopy in 297 cases: conventional rigid instruments vs. small caliber semirigid ureteroscopes. European Urology. 28(2):112-5, 1995.

Scattoni V, Da Pozzo L, Nava L, Broglia L, Galli L, Torelli T, Campo B, Maffezzini M, Rigatti P: Five-year results of neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy plus radical cystectomy in locally advanced bladder cancer. European Urolology. 28 (2):102-7, 1995.

Scattoni V, Da Pozzo L, Colombo R, Nava L, Rigatti P, De Cobelli F, Vanzulli A, Del Maschio A: Dynamic Gadolinium enhanced magnetic resonance imaging in staging of superficial bladder cancer. Journal of Urology. 155: 1594-1599, 1996.

Marcelli G, Bottanelli A, Scattoni V, Baroni GP, Rovellini R, Sciaraffia G, Toia G: Neoplasia vescicale transizionale T1 G3: che fare?  Arch It Urol. 68: 67-69, 1996.

Scattoni V, Bolognesi A, Cozzarini C, Francesca F, Grasso M, Galli L, Torelli T, Campo B, Villa E, Rigatti P: Neoadjuvant CMV chemotherapy plus radical cystectomy in locally advanced bladder cancer: The impact of pathologic response on long term-results. Tumori 82. 463-469, 1996.

Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G, Freschi M, Rigatti P: Percent of free serum prostate-specific antigen and hystological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. European Urology 36:621-630, 1999.

Montorsi F, maga T, Ferini Stambi L, Salonia A, Barbieri L, Scattoni V, Guazzoni G, Losa A, Rigatti P, Pizzini G. Sildenafil taken at bedtime significantly increases nocturnal erections:results of a placebo-controlled study. Urology, 56: 906-911, 2000.

Montorsi F, Salonia A, Guazzoni G, Barbieri L, Colombo R, Brausi M, Scattoni V, Rigatti P, Pizzini G. Transdermal electromotive multi-drug administration for Peyronie’s disease: preliminary results. Journal of Andrology, 21: 85-90, 2000.

Raber M, Scattoni V, Salonia A, Consonni P, Rigatti P: Complicanze del campionamento bioptico multiplo prostatico transrettale. Arch Ital Urol Androl. 72 (4): 249-53, 2000.

Raber M, Scattoni V, Salonia A, Consonni P, Rigatti P: Il campionamento bioptico prostatico transrettale ecoguidato iterattivo in pazienti con esame istologico negativo. Arch Ital Urol Androl 72 (4): 197-9, 2000.

Colombo R, Brausi M, Da Pozzo L, Salonia A, Montorsi F, Scattoni V, Roscigno M, Rigatti P: Thermo-Chemotherapy and Electromotive Drug administration of mitomycin C in superficial bladder cancer eradication. European Urology, 39: 95-100, 2001.

Rigatti P, Scattoni V: Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon. Recenti Prog Med. 93(3): 183-5, 2002.

Scattoni V, Roscigno M, Raber M, Montorsi F, Bertini R, Bua L, Da Pozzo L, Rigatti P: Diagnostic value of ultrasound-guided anastomotic biopsies in patients with PSA elevation (>= 0,4 ng/mL) after radical prostatectomy. Arch Ital Urol Androl. 74 (3): 129-31, 2002.

Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F: A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. Journal of Urology 168 (6): 2486-9, 2002.

Scattoni V, Roscigno M, Raber M, Consonni P, Freschi M, Montorsi F, Pasta A, Colombo R, Nava L, Bua L, Rigatti P: Il ruolo delle biopsie prostatiche mirate sulle aree ipoecogene associate alle biopsie a sestanti nei pazienti con PSA elevato e nella norma. Arch Ital Urol. 74(4): 273-275, 2002.

Roscigno M, Scattoni V, Raber M, Consonni P, Montorsi F, Pasta A, Bertini R, Colombo R, Da Pozzo L, Freschi M, Rigatti P: Il ruolo dell’ecografia della loggia prostatica nella diagnosi delle recidive locali dopo prostatectomia radicale in caso di rialzo del PSA. Arch Ital Urol 74(4): 304-308, 2002.

Scattoni V, Zlotta AR, Nava L, Roscigno M, Montorsi F, Rigatti P: Prostatic transrectal ultrasound (TRUS) guided biopsy schemes and TRUS prostatic lesion-guided biopsies. European Urology Supplements, 1(6): 28-34, 2002.

Montironi R, Mazzucchelli R, Scattoni V, Bostwick DG: Pathological findings in TRUS prostatic biopsy - Diagnostic, prognostic and therapeutic importance. Eur Urol Suppl, 1(6): 60-75, 2002.

Bertaccini A, Scattoni V, Comerci F, Martorana G: The role of TRUS prostate biopsy quantitative histology in predicting the risk of extraprostatic disease. European Urology Supplements, 1(6): 76-82, 2002.

Scattoni V, Roscigno M, Raber M, Consonni P, Da Pozzo L, Rigatti P: Biopsy of the vesico-urethral anastomosis after radical prostatectomy: when and how. European Urology Supplements, 1(6): 89-95, 2002.

Zlotta AR, Scattoni V: What is the future of TRUS in prostate cancer management: new avenues. European Urology Supplements, 1(6): 96, 2002.

Salonia A, Briganti A, Deho’ F, Naspro R, Scapaticci E, Scattoni V, Rigatti P, Montorsi F. Pathophysiology of erectile dysfunction. International Journal of Andrology, 26:129-136, 2003.

Scattoni V, Roscigno M, Raber M, Montorsi F, Da Pozzo L, Guazzoni G, Freschi M, Rigatti P. Multiple vesico-urethral biopsies following a radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. European Urology, 44:407-414, 2003.

Scattoni V, Lazzaro C, Rigatti P. The economics of managing patients with prostate cancer. Archivio Italiano di Urologia e Andrologia. 75(2): 75-87, 2003.

Scattoni V, Montorsi F, Picchio M, Roscigno M, Salonia A, Rigatti P, F. Fazio. Diagnosis of local recurrence after radical prostatectomy. British Journal of Urology International, Mar 01: 93(5), 680-688, 2004.

Roscigno M, Scattoni V, Bertini R, Pasta A, Montorsi F, Rigatti P. Diagnosis of prostate cancer. State of the art. Minerva Urol Nefrol, 56: 123-145, 2004.

Roscigno M, Scattoni V, Freschi M, Raber M, Colombo R, Bertini R, Montorsi F, Rigatti P Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extend repeat biopsy. Urology, 63: 1105-1110, 2004.

Naspro R, Freschi M, Salonia A, Guazzoni G, Di Girolamo V, Colombo R, Scattoni V, Rigatti P, Montorsi F. Holmium Laser enucleation versus transurethal resection of prostate. Are Histological findings comparable? Journal of Urology, 171: 1203-1206, 2004.

Zlotta AR, Roumeguere T, Ravery V, Hoffmann P, Montorsi F, Turkeri L, Dobrovrits M, Scattoni V, Ekane S, Bollens R, Vanden Bossche M, Djavan B, Boccon-Gibod L, Schulman CC; European Society for Urological Oncology. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. European Urolology 46(1):42-9, 2004.

Briganti A, Salonia A, Zanni G, Dehò F, Suardi N, Mazzoccoli B, Scattoni V, Montorsi F. A critical assessment of extracorporeal shock-wave therapy for Peyronie’s disease. Current Sexual Health Reports. 1 (1):19-23, 2004.

Scattoni V, Montorsi F, Picchio M, Fazio F, Roscigno M, Salonia A, Rigatti P. Tecniques for detecting recurrent prostate cancer after radical prostatectomy. American Journal of Urology Review. 2 (11): 555-568, 2004.

Salonia A, Barbieri L, Chen J, Briganti A, Dehò F, Naspro R, Del Carro U, Rokkas C, Scattoni V, Rigatti P, Montorsi F. Comparison of the effect of Sildenafil and Apomorphine SL on nocturnal erections in healthy volunteers: aplacebo –controlled study. European Urology, 47: 524-529, 2005.

Scattoni V, Roscigno M, Freschi M, Dehò F, Raber M, Briganti A, Fantini G, Nava L, Montorsi F, Rigatti P. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. Archivio Italiano di Urologia e Andrologia, 77 (1): 31-36, 2005.

Raber M, Naspro R, Scapaticci E, Salonia A, Scattoni V, Mazzoccoli B, Guazzoni G, Rigatti P, Montorsi F. Dorsal onlay graft urethroplasty using penile skin or buccal mucosa for repair of bulbar urethral stricture: results of a prospective single center study. Eur Urol 48(6):1013-7, 2005.

Scattoni V, Roscigno M, Freschi M, Briganti A, Fantini GV, Bertini R, Salonia A, Montorsi F, Rigatti P. Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation  at 10 to 12 core biopsies. Urology 66: 1043-1047, 2005.

Raber M, Scattoni V, Roscigno M, Rigatti P, Montorsi F. Perianal and intrarectal anaesthesia for transrectal biopsy of the prostate: a prospective randomized study comparing lidocaine-prilocaine cream and placebo. BJU Int 96: 1264-1267, 2005.

Roscigno M, Sangalli M, Mazzoccoli B, Scattoni V, Da Pozzo L, Rigatti P. Medical therapy of prostate cancer A review. Min Urol 57 (2): 71-84, 2005.

Scattoni V, Sangalli M, Roscigno M, Raber M, Gallina A, Fabbri F, Saccà A,Salonia A, Montorsi F, Rigatti P. Detection and diagnosis of prostate cancer: what's new. Arch Ital Urol Androl. 2005 Jun;77(3):173-9.

Galosi AB, Maruzzi D, Milani C, Nava L, Scattoni V, Zambolin T; Gruppo Italiano Biopsia Prostatica. [Prostate biopsy: number and places of sampling].Arch Ital Urol Androl. 2005 Sep;77(3 Suppl 1):33-8.

Scattoni V. Systematic prostate biopsies are more and more often becoming saturation biopsies. Eur Urol. 2006 Aug;50(2):202-4.

Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, Rigatti P,Montorsi F, Karakiewicz PI. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol. 2006 Jun;49(6):1019-26.

Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzoccoli B, Rigatti P, Montorsi F. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol. 2006 Sep;50(3):563-8.

Scattoni V, Montironi R, Mazzucchelli R, Freschi M, Nava L, Losa A, Terrone C, Scarpa RM, Montorsi F, Pappagallo G, Rigatti P. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg. BJU Int. 2006 Jul;98(1):54-8.

Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E, Scattoni V, Friedrich MG, Schlomm T, Haese A, Michl U, Colombo R, Heinzer H, Valiquette L, Rigatti P, Roehrborn CG, Huland H, Karakiewicz PI. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation. BJU Int. 2006.

Salonia A, Suardi N, Naspro R, Mazzoccoli B, Zanni G, Gallina A, Bua L,Scattoni V, Rigatti P, Montorsi F. Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis. Urology. 2006 Aug;68(2):302-6.

Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, Scattoni E, Rigatti P, Montorsi F. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 2006 May;175(5):1817-21.

Montironi R, Scattoni V, Mazzucchelli R, Lopez-Beltran A, Bostwick DG, Montorsi F. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy"). Eur Urol. 2007 Oct;50(4):666-746.

Chun FK, Briganti A, Graefen M, Montorsi F, Porter C, Scattoni V, Gallina A, Walz J, Haese A, Steuber T, Erbersdobler A, Schlomm T, Ahyai SA, Currlin E,Valiquette L, Heinzer H, Rigatti P, Huland H, Karakiewicz PI. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol. 2007 Aug;52(2):436-44.

Roscigno M, Cozzarini C, Scattoni V, Bertini R, Da Pozzo L, Pasta A, MontorsiF, Bolognesi A, Fiorino C, Colombo R, Fazio F, Rigatti P. A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy. Radiother Oncol. 2007 Jan;82(1):30-7.

Chun FK, Briganti A, Graefen M, Porter C, Montorsi F, Haese A, Scattoni V, Borden L, Steuber T, Salonia A, Schlomm T, Latchemsetty K, Walz J, Kim J, Eichelberg C, Currlin E, Ahyai SA, Erbersdobler A, Valiquette L, Heinzer H, Rigatti P, Huland H, Karakiewicz PI. Development and external validation of an extended repeat biopsy nomogram. J Urol. 2007 Feb;177(2):510-5.

Briganti A, Chun FK, Salonia A, Gallina A, Zanni G, Scattoni V, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology. 2007 Jan;69(1):147-51.

Bertaccini A, Fandella A, Prayer-Galetti T, Scattoni V, Galosi AB, Ficarra V, Trombetta C, Gion M, Martorana G; Italian Group for Developing Clinical Practice  Guidelines on Performing Prostate Biopsy. Systematic development of clinicalpractice guidelines for prostate biopsies: a 3-year Italian project. Anticancer. Res. 2007 Jan-Feb;27(1B):659-66.

Briganti A, Chun FK, Hutterer GC, Gallina A, Shariat SF, Salonia A, Scattoni V, Valiquette L, Montorsi F, Rigatti P, Graefen M, Huland H, Karakiewicz PI. Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Eur Urol. 2007 Sep;52(3):733-43.

Scattoni V, Picchio M, Suardi N, Messa C, Freschi M, Roscigno M, Da Pozzo L,  Bocciardi A, Rigatti P, Fazio F. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol. 2007 Aug;52(2):423-9.

Gallina A, Karakiewicz PI, Chun FK, Briganti A, Graefen M, Montorsi F, WalzJ, Jeldres C, Erbersdobler A, Salonia A, Suardi N, Dehò F, Schlomm T, Scattoni V, Haese A, Heinzer H, Valiquette L, Rigatti P, Huland H. Health-insurance status is a determinant of the stage at presentation and of cancer control in European men  treated with radical prostatectomy for clinically localized prostate cancer. BJU  Int. 2007 Jun;99(6):1404-8.

Schaeffer AJ, Montorsi F, Scattoni V, Perroncel R, Song J, Haverstock DC, Pertel PE. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int. 2007 Jul;100(1):51-7.

Scattoni V. Editorial comment on: predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era. Eur Urol. 2008 Feb;53(2):361.

Suardi N, Scattoni V, Briganti A, Salonia A, Naspro R, Gallina A, Cestari A, Colombo R, Karakiewicz PI, Guazzoni G, Rigatti P, Montorsi F. Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement. Eur Urol. 2008 Jun;53(6):1180-5.

Da Pozzo L, Scattoni V, Mazzoccoli B, Rigatti P, Manferrari F, Martorana G, Pietropaolo F, Belgrano E, Prezioso D, Lotti T, Villari D, Nicita G. Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation. BJU Int. 2007 Nov;100(5):1055-9.

Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol. 2007 Nov;52(5):1309-22.

Raber M, Scattoni V, Roscigno M, Dehò F, Briganti A, Salonia A, Gallina A, Di Girolamo V, Montorsi F, Rigatti P. Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial. Eur Urol. 2008 May;53(5):967-73.

Scattoni V. Editorial comment on: Prostate biopsies guided by three-dimensional real-time (4-D) transrectal ultrasonography on a phantom: comparative study versus two-dimensional transrectal ultrasound-guided biopsies.  Eur Urol. 2007 Oct;52(4):1104.

Giovacchini G, Picchio M, Coradeschi E, Scattoni V, Bettinardi V, Cozzarini C, Freschi M, Fazio F, Messa C. [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1065-73.

Roscigno M, Cozzarini C, Bertini R, Scattoni V, Freschi M, Da Pozzo LF, Briganti A, Gallina A, Capitanio U, Colombo R, Giorgio G, Montorsi F, Rigatti P.  Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol. 2008 Apr;53(4):794-802.

Scattoni V. Patient's Reactions to Digital Rectal Examination of the Prostate. Editorial comment. International Braz J Urol.  2008: Vol. 34, p. 576.

Scattoni V. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy: Comment. J Urol, 2008, vol. 179, p. 1750.

Scattoni V. The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes - Comment. J Urol, 2008, vol. 179, p. 1761.

Scattoni V, Roscigno M, Raber M, Dehò F, Maga T, Zanoni M, Riva M, Sangalli M, Nava L, Mazzoccoli B, Freschi M, Guazzoni G, Rigatti P, Montorsi F. Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18  cores than with 12 cores? J Urol. 2008 Apr;179(4):1327-31.

Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and  biochemical recurrence. Eur Urol. 2008 Jul;54(1):118-25.

Scattoni V. Editorial comment on: comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. Eur Urol. 2008 Aug;54(2):379.

Schiavina R, Scattoni V, Castellucci P, Picchio M, Corti B, Briganti A, Franceschelli A, Sanguedolce F, Bertaccini A, Farsad M, Giovacchini G, Fanti S, Grigioni WF, Fazio F, Montorsi F, Rigatti P, Martorana G. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol. 2008 Aug;54(2):392-401.

Scattoni V. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy. what can they teach us? Eur Urol. 2009 Apr;55(4):910.

Colombo R, Naspro R, Bellinzoni P, Fabbri F, Guazzoni G, Scattoni V, Losa A,  Rigatti P. Photodynamic diagnosis for follow-up of carcinoma in situ of the bladder. Ther Clin Risk Manag. 2007 Dec;3(6):1003-7.

Scattoni V. Re: saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Eur Urol. 2008 Sep;54(3):688-90.

Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, Montorsi F, Graefen M, Huland H, Karakiewicz PI. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL  and lower. Cancer. 2008 Nov 15;113(10):2695-703.

Scattoni V. Words of wisdom. Re: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European randomized study of screening for prostate cancer (Rotterdam). Wolters T, Roobol  MJ, Bangma CH, Schröder PH. Eur Urol. 2008 Oct;54(4):945-6.

Cozzarini C, Montorsi F, Fiorino C, Alongi F, Bolognesi A, Da Pozzo LF,Guazzoni G, Freschi M, Roscigno M, Scattoni V, Rigatti P, Di Muzio N. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical  prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):966-74.

Scattoni V, Raber M, Abdollah F, Roscigno M, Dehò F, Angiolilli D, Maccagnano C, Gallina A, Capitanio U, Freschi M, Doglioni C, Rigatti P, Montorsi F. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected  by a 24-core biopsy. Eur Urol. 2010 Jan;57(1):1-8.

Scattoni V. Reply from Authors re: Michael W. Kattan, J. Stephen Jones. The Ultimate Prostate Cancer Biopsy Decision Support Tool. Eur Urol 2010; 57:9-10. Eur Urol 2010, vol. 57, p. 10-11.

Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V, Cozzarini C, Di Muzio N, Rigatti P, Fazio F, Messa C. Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):301-9.

Giovacchini G, Picchio M, Scattoni V, Garcia Parra R, Briganti A, Gianolli L, Montorsi F, Messa C. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1106-16.

Scattoni V, Maccagnano C, Zanni G, Angiolilli D, Raber M, Roscigno M, Rigatti P, Montorsi F. Is extended and saturation biopsy necessary? Int J Urol. 2010 May;17(5):432-47.

Scattoni V, Maccagnano C, Zanni G, Angiolilli D, Raber M, Rigatti P, Montorsi F. Systematic extended and saturation prostate biopsy: when and how. Minerva Urol Nefrol. 2010 Jun;62(2):179-92.

Capitanio U, Briganti A, Gallina A, Suardi N, Karakiewicz PI, Montorsi F, Scattoni V. Predictive models before and after radical prostatectomy. Prostate. 2010 Sep 1;70(12):1371-8.

Giovacchini G, Picchio M, Briganti A, Cozzarini C, Scattoni V, Salonia A, Landoni C, Gianolli L, Di Muzio N, Rigatti P, Montorsi F, Messa C. [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. J Urol. 2010 Sep;184(3):938-43.

Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, Shariat SF, Schröder FH, Scattoni V. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. Eur Urol. 2010 Dec;58(6):851-64.

Abdollah F, Scattoni V, Raber M, Roscigno M, Briganti A, Suardi N, Gallina A, Capitanio U, Freschi M, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F.  The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. BJU Int. 2011 Aug;108(3):366-71.

Abdollah F, Novara G, Briganti A, Scattoni V, Raber M, Roscigno M, Suardi N,  Gallina A, Artibani W, Ficarra V, Cestari A, Guazzoni G, Rigatti P, Montorsi F. Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there  a difference in cancer detection rate? Urology. 2011 Apr;77(4):921-5.

Roscigno M, Scattoni V, Freschi M, Raber M, Angiolilli D, Galosi A, Lacetera V, Montironi R, Muzzonigro G, Deho F, Feroldi L, Deiana G, Chinaglia D, Montorsi  F, Da Pozzo LF. Diagnosis of high-grade prostatic intraepithelial neoplasia: the  impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy. Arch Ital Urol Androl. 2010 Dec;82(4):242-7.

Scattoni V, Villa L. Words of wisdom. Re: Does computed tomography or positron emission tomography/computed tomography contribute to detection of small focal cancers in the prostate? Eur Urol. 2010 Nov;58(5):795.

Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting. Eur Urol. 2011 Aug;60(2):214-22.

Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P (2011). Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223-5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction. Eur Urol 2011;60:226-8. Eur Urol 2011, vol. 60, p. 228-230.

Martino P, Scattoni V, Galosi AB, Consonni P, Trombetta C, Palazzo S, Maccagnano C, Liguori G, Valentino M, Battaglia M, Barozzi L. Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU). World J Urol. 2011 Oct;29(5):595-605.

Maccagnano C, Scattoni V, Roscigno M, Raber M, Angiolilli D, Montorsi F, Rigatti P. Anaesthesia in transrectal prostate biopsy: which is the most effective technique? Urol Int. 2011;87(1):1-13.

Scattoni V, Raber M, Capitanio U, Abdollah F, Roscigno M, Angiolilli D, Maccagnano C, Gallina A, Saccà A, Freschi M, Doglioni C, Rigatti P, Montorsi F. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core  systematic scheme. Eur Urol. 2011 Oct;60(4):834-41.

Rigatti P, Suardi N, Briganti A, Da Pozzo LF, Tutolo M, Villa L, Gallina A, Capitanio U, Abdollah F, Scattoni V, Colombo R, Freschi M, Picchio M, Messa C, Guazzoni G, Montorsi F. Pelvic/retroperitoneal salvage lymph node dissection for  patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. Eur Urol. 2011 Nov;60(5):935-43.

Raber M, Scattoni V, Gallina A, Freschi M, De Almeyda EP, Girolamo VD, Montorsi F, Rigatti P. Does the transrectal ultrasound probe influence prostate cancer detection in patients undergoing an extended prostate biopsy scheme? Results of a large retrospective study. BJU Int. 2012 Mar;109(5):672-7.

Roscigno M, Scattoni V, Freschi M, Abdollah F, Maccagnano C, Galosi A, Lacetera V, Montironi R, Muzzonigro G, Deho F, Deiana G, Belussi D, Chinaglia D,  Montorsi F, Da Pozzo LF. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy. BJU Int. 2012 May;109(9):1329-34.

Guazzoni G, Lazzeri M, Nava L, Lughezzani G, Larcher A, Scattoni V, Gadda GM, Bini V, Cestari A, Buffi NM, Freschi M, Rigatti P, Montorsi F. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate  health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Eur Urol. 2012 Mar;61(3):455-66.

Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy. BJU Int. 2012; (110), Issue 2b: E64–E68.

Lazzeri M, Lughezzani G, Larcher A, Lista G, Gadda GM, Scattoni V, Cestari A, Buffi N, Rigatti P, Montorsi F, Guazzoni G. Reply to Sergey Tadtayev, Thomas A. McNicholas, and Gregory B. Boustead's Letter to the Editor re: Giorgio Guazzoni,  Massimo Lazzeri, Luciano Nava, et al. Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer. Eur Urol 2012;61:455-66.

Maccagnano C, Gallina A, Roscigno M, Raber M, Capitanio U, Saccà A, Pellucchi F, Suardi N, Abdollah F, Montorsi F, Rigatti P, Scattoni V. Prostate Saturation Biopsy following a First Negative Biopsy: State of the Art. Urol Int. 2012;89:126-35.

Lughezzani G, Lazzeri M, Larcher A, Lista G, Scattoni V, Cestari A, Buffi NM, Bini V, Guazzoni G. Development and Internal Validation of a Prostate Health Index Based Nomogram for Predicting Prostate Cancer at Extended Biopsy. J Urol. 2012 Oct;188(4):1144-50.

Lazzeri M, Briganti A, Scattoni V, Lughezzani G, Larcher A, Gadda GM, Lista G, Cestari A, Buffi N, Bini V, Freschi M, Rigatti P, Montorsi F, Guazzoni G. Serum Index Test %[-2]proPSA and Prostate Health Index are More Accurate than Prostate Specific Antigen and %fPSA in Predicting a Positive Repeat Prostate Biopsy. J Urol. 2012 Oct;188(4):1137-43.

Villa L, Capitanio U, Briganti A, Abdollah F, Suardi N, Salonia A, Gallina A, Freschi M, Russo A, Castiglione F, Bianchi M, Rigatti P, Montorsi F, Scattoni V. The Number Of Cores Taken Is A Major Predictor Of Insignificant Prostate Cancer In Patients Diagnosed With A Single Microfocus At Initial Biopsy: Implications For The Selection Of Candidates Suitable For Active Surveillance. J Urol. 2013 Mar;189(3):854-9.

Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS. Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care. Eur Urol. 2013 Feb;63(2):214-30

Maccagnano C, Pellucchi F, Rocchini L, Ghezzi M, Scattoni V, Montorsi F, Rigatti P, Colombo R. Diagnosis and Treatment of Bladder Endometriosis: State of the Art. Urol Int. 2012;89(3):249-58.

Bertaccini A, Giampaoli M, Cividini R, Gattoni GL, Sanseverino R, Realfonso T,Napodano G, Fandella A, Guidoni E, Prezioso D, Galasso R, Cicalese C, Scattoni V, Armenio A, Conti G, Corinti M, Spasciani R, Liguori G, Lampropoulou N, Martorana G. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project. Arch Ital Urol Androl. 2012 Sep;84(3):117-22.

Lazzeri M, Haese A, de la Taille A, Palou Redorta J, McNicholas T, Lughezzani G, Scattoni V, Bini V, Freschi M, Sussman A, Ghaleh B, Le Corvoisier P, Alberola Bou J, Esquena Fernández S, Graefen M, Guazzoni G.: Serum Isoform [-2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2-10 ng/ml: A Multicentric European Study.. Eur Urol. 2013 Jun;63(6):986-94.

Cormio L, Scattoni V, Lorusso F, Perrone A, Di Fino G, Selvaggio O, Sanguedolce F, Bufo P, Montorsi F, Carrieri G. Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? World J Urol. 2014 Apr; 32(2): 341-6.

Briganti A, Bianchi M, Sun M, Suardi N, Gallina A, Abdollah F, Bertini R, Colombo R, Girolamo VD, Salonia A, Scattoni V, Karakiewicz PI, Guazzoni G, Rigatti P, Montorsi F. Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre. BJU Int. 2013 Jun;111(8):1222-30.

Lazzeri M, Haese A, de la Taille A, Palou Redorta J, McNicholas T, Lughezzani  G, Scattoni V, Bini V, Freschi M, Sussman A, Ghaleh B, Le Corvoisier P, Alberola Bou J, Esquena Fernández S, Graefen M, Guazzoni G. Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study. Eur Urol. 2013 Jun;63(6):986-94.

Scattoni V, Lazzeri M, Lughezzani G, De Luca S, Passera R, Bollito E, Randone  D, Abdollah F, Capitanio U, Larcher A, Lista G, Gadda GM, Bini V, Montorsi F, Guazzoni G. Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy. J Urol. 2013 Aug;190(2):496-501.

Maccagnano C, Pellucchi F, Rocchini L, Ghezzi M, Scattoni V, Montorsi F, Rigatti P, Colombo R. Ureteral endometriosis: proposal for a diagnostic and therapeutic algorithm with a review of the literature. Urol Int. 2013;91(1):1-9.

Abdollah F, Suardi N, Capitanio U, Gallina A, Sun M, Villa L, Scattoni V, Bianchi M, Tutolo M, Fossati N, Karakiewicz P, Rigatti P, Montorsi F, Briganti A. Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance. BJU Int. 2013 Aug;112(4): E234-42.

Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, Rosario DJ, Scattoni V, Lotan Y. Systematic Review of Complications of Prostate Biopsy. Eur Urol. 2013 Dec;64(6):876-92.

Martino P, Galosi AB, Bitelli M, Consonni P, Fiorini F, Granata A, Gunelli R, Liguori G, Palazzo S, Pavan N, Scattoni V, Virgili G; Imaging Working Group-Societa Italiana Urologia (SIU); Società Italiana Ecografia Urologica Andrologica Nefrologica (SIEUN). Practical recommendations for performing ultrasound scanning in the urological and andrological fields. Arch Ital Urol Androl. 2014 Mar 28;86(1):56-78.

Scattoni V, Maccagnano C, Capitanio U, Gallina A, Briganti A, Montorsi F.: Random biopsy: when, how many and where to take the cores? World J Urol. 2014 Aug;32(4):859-69.

Villa L, Salonia A, Capitanio U, Scattoni V, Abdollah F, Suardi N, Dell'Oglio P, Freschi M, Montorsi F, Briganti A: The number of cores at first biopsy may suggest the need for a confirmatory biopsy in patients eligible for active surveillance-implication for clinical decision making in the real-life setting. Urology. 2014 Sep;84(3):634-41.

Scattoni V, Russo A, Di Trapani E, Capitanio U, La Croce G, Montorsi F. Repeated biopsy in the detection of prostate cancer: When and how many cores. Arch Ital Urol Androl. 2014.

Suardi N, Gandaglia G, Gallina A, Di Trapani E, Scattoni V, Vizziello D, Cucchiara V, Bertini R, Colombo R, Picchio M, Giovacchini G, Montorsi F, Briganti A. Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years. Eur Urol. 2015, 67(2), pp.299-309.

Ploussard G, Scattoni V, Giannarini G, Jones JS. Approaches for Initial Prostate Biopsy and Antibiotic Prophylaxis. European Urology Focus, Volume 1, Issue 2, September 2015, Pages 109-116.

Rainato G, Fabricio AS, Zancan M, Peloso L, Dittadi R, Barichello M, Fandella A, Scattoni V, Gion M. Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis.  Int J Biol Markers. 2016, 31(3), pp.e317-e323.

Fandella, A., Scattoni, V., Galosi, A., Pepe, P., Fiorentino, M., Gaudiano, C., Giampaoli, M., Gunelli, R., Martino, P., Montanaro, V., Montironi, R., Pierangeli, T.l, Stabile, A., Bertaccini, A. Italian prostate biopsies group: 2016 updated guidelines insights. Anticancer Research. Volume 37, Issue 2, 2017, Pages 413-424.

Giganti F, Coppola A, Ambrosi A, Ravelli S, Esposito A, Freschi M, Briganti A, Scattoni V, Salonia A, Gallina A, Dehò F, Cardone G, Balconi G, Gaboardi F, Montorsi F, Maschio AD, De Cobelli F. Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: Development and external validation of a nomogram of clinical use. Urol Oncol. Volume 34, Issue 7, 1 July 2016, Pages 291.e9-291.e17.

Bellardita, L.Email Author, Damiano, R., Porpiglia, F., Scattoni, V., Amodeo, A., Bortolus, R., Lapini, A., Cocci, A., Cicalese, V., Caponera, M., Mastrangelo, P., Francesca, F., Valdagni, R., Taverna, G., di Trapani, D., Leonardi, R., Minocci, D., Gaboardi, F., Montanari, E., Conti, G. Adaptation and validation of an Italian version of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI). European review for medical and pharmacological sciences. Volume 20, Issue 13, 1 July 2016, Pages 2773-2778.

Stabile, A., Dell'Oglio, P., Gandaglia, G., Fossati, N., Brembilla, G., Cristel, G., Dehò, F., Scattoni, V., Maga, T., Losa, A., Gaboardi, F., Cardone, G., Esposito, A., De Cobelli, F., Del Maschio, A., Montorsi, F., Briganti, A. Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. European Urology Oncology. Volume 1, Issue 2, June 2018, Pages 120-128.

V. Scattoni: Editorial comment to Ultrasound for prostate cancer detection and localization. Journal of Urology, 2019, 202(6), pp.117.

Boeri, L., Capogrosso, P., Ventimiglia, E., Fontana, M., Sampogna, G., Zanetti, S.P., Pozzi, E., Zuabi, R., Schifano, N., Chierigo, F., Longo, F., Gadda, F., Dell'Orto, P.G., Scattoni, V., Montorsi, F., Montanari, E., Salonia, A. Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate in Patients Under Either Anticoagulation or Antiplatelet. European Urology Focus Volume 6, Issue 4, 15 July 2020, Pages 720-728.

Fallara, G., Capogrosso, P., Schifano, N., Costa, A., Candela, L., Cazzaniga, W., Boeri, L., Belladelli, F., Scattoni, V., Salonia, A. en-year Follow-up Results After Holmium Laser Enucleation of the Prostate. European Urology Focus 2020 (In press).

EAU-EBU update series: Briganti A, Salonia A, Gallina A, Suardi N, Deho’ F, Fabbri F, Zanni G, Scattoni V, Rigatti P, Montorsi F.  Potency after Radical Prostatectomy: From New Techniques to Better Results. EAU-EBU update series 4 (2006) 33–45.